Furthermore, MNX1-AS1 is implicated in enhancing the expression of ITGA6/PI3K/AKT pathway components in BC cells, thus contributing to malignant progression and paclitaxel resistance in BC. This evidence concerns the gene MNX1 and breast cancer.